In vivo and in vitro function of human UDP-galactose 4′-epimerase variants
2011

Function of Human UDP-galactose 4′-epimerase Variants

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): McCorvie Thomas J., Wasilenko Jamie, Liu Ying, Fridovich-Keil Judith L., Timson David J.

Primary Institution: Queen’s University Belfast

Hypothesis

The study investigates the in vivo and in vitro functions of various human UDP-galactose 4′-epimerase variants to understand their effects on galactose sensitivity.

Conclusion

The M284K variant of UDP-galactose 4′-epimerase can function in vivo despite showing near-zero activity in vitro, highlighting the limitations of in vitro assays for predicting enzyme function.

Supporting Evidence

  • Seven out of eight GALE variants followed the expected relationship between in vitro and in vivo function.
  • The M284K variant was able to alleviate galactose sensitivity in yeast despite showing low activity in vitro.
  • Biochemical analyses indicated that M284K-hGALE is unstable and largely unfolded in vitro.

Takeaway

Some changes in a protein can make it work well inside a living cell but not in a test tube, like how the M284K version of a protein helps yeast grow even though it looks broken when tested outside the cell.

Methodology

The study involved expressing human GALE variants in a yeast model and assessing their activity and stability through various biochemical assays.

Limitations

The study primarily focuses on yeast models, which may not fully replicate human cellular environments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.biochi.2011.06.009

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication